Free Trial

Concurrent Investment Advisors LLC Buys 44,564 Shares of Morgan Stanley $MS

Morgan Stanley logo with Finance background
Image from MarketBeat Media, LLC.

Key Points

  • Concurrent Investment Advisors LLC boosted its Morgan Stanley stake by 140.3%, buying 44,564 shares in Q4 to hold 76,338 shares worth about $13.55 million.
  • Morgan Stanley beat quarterly estimates with $3.43 EPS vs $3.02 and $20.58 billion revenue, and declared a quarterly dividend of $1.00 (annualized $4.00, ~2.1% yield).
  • Institutional ownership is high (about 84.19%), several analysts have raised price targets into the ~$205–220 area while consensus is a "Hold" (average PT $201.89), and insiders have recently trimmed stakes.
  • MarketBeat previews top five stocks to own in May.

Concurrent Investment Advisors LLC boosted its stake in shares of Morgan Stanley (NYSE:MS - Free Report) by 140.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 76,338 shares of the financial services provider's stock after purchasing an additional 44,564 shares during the period. Concurrent Investment Advisors LLC's holdings in Morgan Stanley were worth $13,552,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in MS. Junto Capital Management LP bought a new position in Morgan Stanley during the third quarter valued at approximately $170,037,000. Marshall Wace LLP lifted its position in Morgan Stanley by 40.2% during the third quarter. Marshall Wace LLP now owns 2,933,604 shares of the financial services provider's stock valued at $466,326,000 after purchasing an additional 841,263 shares during the period. Ameriprise Financial Inc. lifted its position in Morgan Stanley by 6.1% during the third quarter. Ameriprise Financial Inc. now owns 14,260,650 shares of the financial services provider's stock valued at $2,267,847,000 after purchasing an additional 822,120 shares during the period. Two Sigma Investments LP lifted its position in Morgan Stanley by 150.3% during the third quarter. Two Sigma Investments LP now owns 1,234,969 shares of the financial services provider's stock valued at $196,311,000 after purchasing an additional 741,651 shares during the period. Finally, Danske Bank A S bought a new position in Morgan Stanley during the third quarter valued at approximately $104,097,000. Institutional investors own 84.19% of the company's stock.

More Morgan Stanley News

Here are the key news stories impacting Morgan Stanley this week:

  • Positive Sentiment: MSIM launched a Stablecoin Reserves Portfolio (MSNXX) aimed at stablecoin issuers — a new money‑market/reserve solution that positions Morgan Stanley as a provider of regulatory‑aligned cash reserves for the growing payment‑stablecoin market. This is strategically important because it can win fee income, strengthen MS’s digital‑assets franchise and deepen client relationships in crypto. MS stablecoin reserves fund
  • Positive Sentiment: Third‑party analyst activity is supportive: BNP Paribas Exane raised its price target on MS to $205 (from $195), citing upside vs. the share price — a clear vote of confidence that can help investor sentiment. BNP Paribas raises PT
  • Positive Sentiment: Market commentary and research note coverage (Zacks, other outlets) continue to highlight MS as a solid momentum/dividend and growth play — reinforcing buy‑side interest in the wealth‑management and capital‑markets franchises that drive recurring revenue. Zacks momentum coverage
  • Neutral Sentiment: Morgan Stanley expanded market infrastructure ties (e.g., added as an NZX clearing participant) and continues to show institutional product rollout — incremental business development but not immediately earnings‑material. NZX clearing participant
  • Neutral Sentiment: MS has been cited across media coverage for analyst model updates and sector research (examples: packaged‑foods coverage updates, biopharma model tweaks). These signals illustrate active franchise research but don’t directly move MS’s revenues. MS analyst activity examples
  • Negative Sentiment: Intraday weakness likely reflects profit‑taking/positioning and options‑oriented selling: Schaeffer and other options commentators recently highlighted bearish trades tied to MS, which can amplify short‑term downward pressure. Lower-than‑average volume today (per background data) also suggests a thinner market exacerbating small sell flows. Schaeffer options note

Morgan Stanley Stock Down 0.3%

MS opened at $188.13 on Friday. The company has a current ratio of 0.81, a quick ratio of 0.81 and a debt-to-equity ratio of 3.39. Morgan Stanley has a 1-year low of $112.03 and a 1-year high of $194.59. The company has a market capitalization of $297.50 billion, a PE ratio of 17.04, a PEG ratio of 1.42 and a beta of 1.19. The firm's 50 day simple moving average is $170.25 and its two-hundred day simple moving average is $171.90.

Morgan Stanley (NYSE:MS - Get Free Report) last released its quarterly earnings results on Wednesday, April 15th. The financial services provider reported $3.43 earnings per share for the quarter, topping the consensus estimate of $3.02 by $0.41. Morgan Stanley had a net margin of 14.65% and a return on equity of 17.89%. The business had revenue of $20.58 billion for the quarter, compared to the consensus estimate of $19.23 billion. During the same period last year, the firm earned $2.60 earnings per share. The company's quarterly revenue was up 16.0% on a year-over-year basis. As a group, equities analysts forecast that Morgan Stanley will post 11.8 EPS for the current year.

Morgan Stanley Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Thursday, April 30th will be given a $1.00 dividend. The ex-dividend date is Thursday, April 30th. This represents a $4.00 annualized dividend and a yield of 2.1%. Morgan Stanley's dividend payout ratio (DPR) is presently 36.23%.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on the stock. BMO Capital Markets increased their price objective on shares of Morgan Stanley from $190.00 to $220.00 and gave the company an "outperform" rating in a research report on Monday, April 20th. Keefe, Bruyette & Woods increased their price objective on shares of Morgan Stanley from $210.00 to $218.00 and gave the company an "outperform" rating in a research report on Thursday, April 16th. Royal Bank Of Canada restated a "sector perform" rating and set a $207.00 price objective on shares of Morgan Stanley in a research report on Thursday, April 16th. The Goldman Sachs Group increased their price objective on shares of Morgan Stanley from $186.00 to $205.00 and gave the company a "neutral" rating in a research report on Thursday, April 16th. Finally, Evercore increased their price objective on shares of Morgan Stanley from $190.00 to $210.00 and gave the company an "outperform" rating in a research report on Thursday, April 16th. Ten investment analysts have rated the stock with a Buy rating and thirteen have assigned a Hold rating to the company. Based on data from MarketBeat, Morgan Stanley currently has a consensus rating of "Hold" and an average price target of $201.89.

Get Our Latest Stock Report on Morgan Stanley

Insiders Place Their Bets

In other news, insider Andrew M. Saperstein sold 51,668 shares of the stock in a transaction on Thursday, April 16th. The shares were sold at an average price of $188.59, for a total value of $9,744,068.12. Following the completion of the sale, the insider directly owned 282,142 shares of the company's stock, valued at $53,209,159.78. This represents a 15.48% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Daniel A. Simkowitz sold 32,968 shares of the stock in a transaction on Friday, January 30th. The stock was sold at an average price of $182.61, for a total transaction of $6,020,286.48. Following the completion of the sale, the insider directly owned 357,342 shares of the company's stock, valued at approximately $65,254,222.62. This trade represents a 8.45% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders have sold 110,444 shares of company stock worth $20,665,049. Company insiders own 0.17% of the company's stock.

Morgan Stanley Profile

(Free Report)

Morgan Stanley NYSE: MS is a global financial services firm headquartered in New York City. Founded in 1935 by Henry S. Morgan and Harold Stanley, the company provides a broad range of investment banking, securities, wealth management and investment management services to corporations, governments, institutions and individual investors. Leadership has been guided by a senior executive team and board of directors; James P. Gorman has served as the company's chief executive and chairman in recent years.

The firm's primary business activities are organized around three principal businesses: Institutional Securities, Wealth Management and Investment Management.

Further Reading

Institutional Ownership by Quarter for Morgan Stanley (NYSE:MS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Morgan Stanley Right Now?

Before you consider Morgan Stanley, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Morgan Stanley wasn't on the list.

While Morgan Stanley currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy Before SpaceX Goes Public Cover

A forward-looking investment report spotlighting the seven space companies best positioned to benefit from accelerating commercialization in 2026. It explores key industry trends, major growth catalysts, and the stocks shaping the next phase of the space economy—from launch leaders and satellite networks to data, defense, and in-space infrastructure.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines